Furthermore, people with DS have higher CSF levels of YKL-40 (chitinase 3-like protein 1), a biomarker of neuroinflammation and astrogliosis, than carriers of EOAD causal mutations, both before and after a dementia diagnosis (Fagan et al., 2021). The gene discussed is CHI3L1; the disease is Dravet syndrome.